Prevention of Mucositis in Patients With Head and Neck Cancer Treated With Radiotherapy
Primary Purpose
Radiation- Induced Mucositis, Adverse Effect of Radiation Therapy, Head and Neck Cancer
Status
Completed
Phase
Not Applicable
Locations
Thailand
Study Type
Interventional
Intervention
Normal saline with salt/Soda
Clinacanthus nutans
Boesenbergia rotunda
Sponsored by
About this trial
This is an interventional prevention trial for Radiation- Induced Mucositis focused on measuring Radiation- induced mucositis, Head and Neck Cancer, Radiation therapy side effect
Eligibility Criteria
Inclusion Criteria:
- Aged 15 years old or older,
- Diagnosed with Head and Neck cancer
- On treatment of external Radiation therapy
Exclusion Criteria:
- Pregnant
- Previously underwent external Radiation therapy
- Illiterate
Sites / Locations
- Chulabhorn Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Active Comparator
Experimental
Experimental
Arm Label
Normal saline with salt/Soda
Clinacanthus nutans
Boesenbergia rotunda
Arm Description
Normal saline with salt/soda rinse 4 times a day/everyday and for each time 15 ml.
Clinacanthus nutans in form of mouth wash rinse 4 times a day/everyday and for each time 15 ml.
Boesenbergia rotunda in form of mouth wash 4 times a day/everyday and for each time 15 ml.
Outcomes
Primary Outcome Measures
Change of mucositis grading
RTOG (Radiation Therapy Oncology Group) Grade0: none Grade 1 : oral soreness, erythema Grade 2 : oral erythema, ulcer, solid diet tolerated Grade 3 : oral ulcers, liquid diet only Grade 4 : oral alimentation impossible
Secondary Outcome Measures
Patient satisfaction with the mouth wash
Scoring 1-4 not satisfied slightly satisfied moderately satisfied very satisfied
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03359187
Brief Title
Prevention of Mucositis in Patients With Head and Neck Cancer Treated With Radiotherapy
Official Title
Prevention of Radiation-induced Mucositis in Patients With Head and Neck Cancer Treated With Radiotherapy : A Double-blind Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
August 2020
Overall Recruitment Status
Completed
Study Start Date
February 2016 (Actual)
Primary Completion Date
March 2018 (Actual)
Study Completion Date
March 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Chulabhorn Hospital
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Prevention of radiation-induced mucositis in patients with head and neck cancer treated with radiotherapy : A Double-blind Randomized Controlled Trial
Detailed Description
To compare the effect of each herb extracts in form of mouth wash to protect or delay the onset of the radiation-induced mucositis from the adverse effects of radiation therapy in patients with head and neck cancer.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Radiation- Induced Mucositis, Adverse Effect of Radiation Therapy, Head and Neck Cancer
Keywords
Radiation- induced mucositis, Head and Neck Cancer, Radiation therapy side effect
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Experimental design in 3 groups
Masking
ParticipantCare ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
120 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Normal saline with salt/Soda
Arm Type
Active Comparator
Arm Description
Normal saline with salt/soda rinse 4 times a day/everyday and for each time 15 ml.
Arm Title
Clinacanthus nutans
Arm Type
Experimental
Arm Description
Clinacanthus nutans in form of mouth wash rinse 4 times a day/everyday and for each time 15 ml.
Arm Title
Boesenbergia rotunda
Arm Type
Experimental
Arm Description
Boesenbergia rotunda in form of mouth wash 4 times a day/everyday and for each time 15 ml.
Intervention Type
Other
Intervention Name(s)
Normal saline with salt/Soda
Intervention Description
Head and Neck cancer Patients have to rinse 4 times a day/everyday for 15 ml. each time during and after completed the radiation treatment
Intervention Type
Other
Intervention Name(s)
Clinacanthus nutans
Intervention Description
Head and Neck cancer Patients have to rinse 4 times a day/everyday for 15 ml. each time during and after completed the radiation treatment
Intervention Type
Other
Intervention Name(s)
Boesenbergia rotunda
Intervention Description
Head and Neck cancer Patients have to rinse 4 times a day/everyday for 15 ml. each time during and after completed the radiation treatment
Primary Outcome Measure Information:
Title
Change of mucositis grading
Description
RTOG (Radiation Therapy Oncology Group) Grade0: none Grade 1 : oral soreness, erythema Grade 2 : oral erythema, ulcer, solid diet tolerated Grade 3 : oral ulcers, liquid diet only Grade 4 : oral alimentation impossible
Time Frame
Change from baseline mucositis grading 1,2, 3, 4, 5 , 6 , 7, 8, 9 week and at 1 month after completed Radiation therapy
Secondary Outcome Measure Information:
Title
Patient satisfaction with the mouth wash
Description
Scoring 1-4 not satisfied slightly satisfied moderately satisfied very satisfied
Time Frame
The last fraction of radiation therapy, through study completion, an average of 1 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
15 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Aged 15 years old or older,
Diagnosed with Head and Neck cancer
On treatment of external Radiation therapy
Exclusion Criteria:
Pregnant
Previously underwent external Radiation therapy
Illiterate
Facility Information:
Facility Name
Chulabhorn Hospital
City
Bangkok
ZIP/Postal Code
10210
Country
Thailand
12. IPD Sharing Statement
Plan to Share IPD
Yes
Citations:
PubMed Identifier
35218685
Citation
Kongwattanakul S, Petchann N, Petroch P, Thanthong S, Tungfung S, Chamchod S, Pitiporn S, Nantajit D. Prophylactic management of radiation-induced mucositis using herbal mouthwash in patients with head and neck cancer: an assessor-blinded randomized controlled trial. J Complement Integr Med. 2022 Feb 28;19(3):771-780. doi: 10.1515/jcim-2021-0457. eCollection 2022 Sep 1.
Results Reference
derived
Learn more about this trial
Prevention of Mucositis in Patients With Head and Neck Cancer Treated With Radiotherapy
We'll reach out to this number within 24 hrs